Shawn P. Cahill, PhD
- 2Articles
- 8.4KReads
- 2013–2015Active
- 20Collaborators
- 58Citations
About
Shawn P. Cahill, PhD, has published research on treatment approaches for Obsessive-Compulsive Disorder, focusing on augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone. Cahill's work includes clinical trials examining six-month outcomes and follow-up in adults with obsessive-compulsive and related disorders. Collaborators frequently include Chang-Gyu Hahn, David Rosenfield, Donna Vermes, Edna B. Foa, and Helen Blair Simpson.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
